Abstract

Many new drug discoveries technologies have promised to rescue the steady decline in pharmaceutical R&D efficiency, yet Eroom's Law still haunts our industry. At the same time, widespread irreproducibility in preclinical research findings undermines our confidence in our understanding of disease biology. Arctoris offers a new solution for drug discovery researchers, bringing the benefits of automation - consistency, precision, and a reduction in human error - to processes beyond just high-throughput screening. Arctoris makes the highest standards of preclinical research data accessible to all, enabling better decision making and faster progress in early-stage drug discovery and development.